Dr. Nikitin bringing extensive experience in biopharmaceutical development.

The company’s selection at Biotech Showcase provides a powerful platform to showcase its latest advancements.

Dr. Ramdev Puligedda presented groundbreaking research at Antibody Engineering & Therapeutics 2024, highlighting the company’s innovative use of artificial intelligence (AI) in monoclonal antibody discovery.

OCMS Bio's expansion to a new state-of-the-art facility in King of Prussia boosts our antibody research and preclinical pipeline.